Lead competitively inhibits calcium-dependent synaptic transmission in the bullfrog sympathetic ganglion

Abstract

MANY polyvalent cations have been used in studies of synaptic transmission either as tools for gaining a better understanding of synaptic processes or, in their own right, as potentially toxic substances1–7. Inorganic lead although long known to have neurotoxic effects, has not been studied extensively at the synaptic level until recently. Kostial and Vouk8 found that lead blocked transmission in the perfused superior cervical ganglion of the cat in vitro by reducing the amount of acetylcholine released from presynaptic nerve terminals without affecting the response of ganglion cells to applied acetylcholine. The addition of excess calcium to the perfusion solution restored acetylcholine output and relieved the lead block. Manalis and Cooper9, working with the frog sciatic nerve-sartorius muscle preparation in vitro, showed that lead depresses phasic transmitter release evoked by nerve stimulation and increases spontaneous release as evidenced by an increase in frequency of miniature endplate potentials. Lead had only a weak, curare-like effect on the postsynaptic response to applied acetylcholine. In this paper we show, using electrophysiological techniques, that PbCl2 blocks synaptic transmission pre-synaptically by competitive inhibition of calcium. In support of this data, we further show, using 45Ca, that lead in fact does reduce the uptake of calcium by preganglionic nerve terminals.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Weakly, J. N., J. Physiol., Lond., 234, 597–612 (1973).

  2. 2

    Meiri, U., and Rahamimoff, R., Science, 176, 308–309 (1972).

  3. 3

    Guerrero, S., and Riker, W. K., J. Pharmac. exp. Ther., 186, 152–159 (1973).

  4. 4

    Manalis, R. S., and Cooper, G. P., Nature, 257, 690–691 (1975).

  5. 5

    Kostial, K., and Landeka, M., Experientia, 31, 834–835 (1975).

  6. 6

    DeBassio, W. A., Schnitzler, R. M., and Parsons, R. L., J. Neurobiol., 2, 263–278 (1971).

  7. 7

    Del Castillo, J., and Engback, L., J. Physiol., Lond., 124, 370–384 (1954).

  8. 8

    Kostial, K., and Vouk, V. B., Br. J. Pharmac., 12, 219–222 (1957).

  9. 9

    Manalis, R. S., and Cooper, G. P., Nature, 243, 354–356 (1973).

  10. 10

    Koketsu, K., and Yamamoto, K., Br. J. Pharmac., 50, 69–77 (1974).

  11. 11

    Dodge, F. A., and Rahamimoff, R., J. Physiol., Lond., 193, 419–432 (1967).

  12. 12

    Dunant, Y., and Dolivo, M., Brain Res., 10, 268–270 (1968).

  13. 13

    Blaustein, M. P., Science, 172, 391–393 (1971).

  14. 14

    Carroll, P. T., Silbergeld, E. K., and Goldberg, A. M., Neurosci. Abstr., 1, 250 (1975).

  15. 15

    Goyer, R. A., and Mahaffey, K. R., Environ. Hlth Perspect., 2, 73–80 (1972).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.